skip to Global Navigation Bar skip to main content

homeHome > About Us > Recruitment > News

News

뉴스
No Subject Data
233 Daewoong Pharmaceutical’s Osong Plant introduced its state-of-the-art production facilities to high government officials on health and medicine from Central and South America 2017-04-04
232 Daewoong Pharmaceutical seeks to build industry-university-government network in Biomecca Indonesia for an open collaboration opportunity 2017-03-27
231 Nabota, Daewoong Pharmaceutical’s botulinum toxin, enters markets in Middle East and Vietnam 2017-03-20
230 Daewoong Pharmaceutical ‘Daewoong Infion’ receives Most Outstanding Pharmaceutical Company Award in Indonesia 2017-03-17
229 Daewoong Pharmaceutical’s India Research Center sets its vision as the global RA hub 2017-03-09
228 Daewoong Pharmaceutical’s anemia medication Epodion approved in Indonesia for January Launch 2017-01-05
227 Daewoong Pharmaceutical targeting 200 billion won overseas sales for Urusa by 2020… Effectively entering domestic and global markets 2016-12-22
226 Daewoong Pharmaceutical and Indonesia University collaborate to develop biopharmaceutical 2016-12-01
225 Daewoong Pharmaceuticals holds a symposium to promote the excellence of Olmesartan medications including ‘Olmetec’ at International Society of Hypertension 2016-09-28
224 Daewoong Pharmaceuticals expands entry to new markets with license in Mexico and India on Nabota 2016-09-22
first page previous page 1  / 2  / 3  / 4  / 5  / 6  / 7  / 8  / 9  / 10  / next page last page
News Search